Literature DB >> 29606255

Recent advances in the physiopathology of IgA nephropathy.

Renato C Monteiro1.   

Abstract

Immunoglobulin A nephropathy or Berger's disease is the most common type of primary glomerulonephritis, which is characterized by IgA1-containing immune-deposits in the glomerular mesangium. Microscopic haematuria and proteinuria are the most common presentations. Mesangial cell proliferation with IgA deposition is found on renal biopsy. Mechanims of the disease implicate at least four key molecules have been implicated in immune complex formation: galactose-deficient IgA1, autoantibodies anti-galactose-deficient-IgA1, soluble CD89 (Fc receptor for IgA) and the CD71 mesangial IgA receptor (transferrin receptor). These factors associated with environmental factors (antigens, food and microbiota) are correlated with disease progression and recurrence after transplantation. This review exploits recent data on the role of these molecular players of the disease, which may improve future therapeutic management of immunoglobulin A nephropathy.
Copyright © 2018 Association Société de néphrologie. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Fc receptor; Glomerulonephritis; Glycosylation; IgA nephropathy; Immunoglobulin A

Mesh:

Substances:

Year:  2018        PMID: 29606255     DOI: 10.1016/j.nephro.2018.02.004

Source DB:  PubMed          Journal:  Nephrol Ther        ISSN: 1769-7255            Impact factor:   0.722


  13 in total

Review 1.  IgA vasculitis nephritis in children and adults: one or different entities?

Authors:  Licia Peruzzi; Rosanna Coppo
Journal:  Pediatr Nephrol       Date:  2020-11-20       Impact factor: 3.714

2.  Polyethylene Glycol 3350 Crystal Nephropathy in Association With Glomerular Mesangial Immunoglobin A Deposition.

Authors:  Rasha Aly; Ratna Acharya; Xu Zeng; Kiran Upadhyay
Journal:  J Med Cases       Date:  2022-09-28

Review 3.  Clinical and Pathophysiological Insights Into Immunological Mediated Glomerular Diseases in Childhood.

Authors:  Antonio Mastrangelo; Jessica Serafinelli; Marisa Giani; Giovanni Montini
Journal:  Front Pediatr       Date:  2020-05-12       Impact factor: 3.418

4.  ELL2 Is Downregulated and Associated with Galactose-Deficient IgA1 in IgA Nephropathy.

Authors:  Youxia Liu; Jie Zheng; Na Zhao; Junya Jia; Tiekun Yan
Journal:  Dis Markers       Date:  2019-06-04       Impact factor: 3.434

Review 5.  Emerging Modes of Treatment of IgA Nephropathy.

Authors:  Dita Maixnerova; Vladimir Tesar
Journal:  Int J Mol Sci       Date:  2020-11-28       Impact factor: 5.923

6.  Rifaximin as a Potential Treatment for IgA Nephropathy in a Humanized Mice Model.

Authors:  Vincenzo Di Leo; Patrick J Gleeson; Fabio Sallustio; Carine Bounaix; Jennifer Da Silva; Gesualdo Loreto; Sanae Ben Mkaddem; Renato C Monteiro
Journal:  J Pers Med       Date:  2021-04-16

7.  Fecal Microbiota Transplantation Modulates Renal Phenotype in the Humanized Mouse Model of IgA Nephropathy.

Authors:  Gabriella Lauriero; Lilia Abbad; Mirco Vacca; Giuseppe Celano; Jonathan M Chemouny; Maria Calasso; Laureline Berthelot; Loreto Gesualdo; Maria De Angelis; Renato C Monteiro
Journal:  Front Immunol       Date:  2021-10-12       Impact factor: 7.561

Review 8.  The mucosal immune system and IgA nephropathy.

Authors:  Loreto Gesualdo; Vincenzo Di Leo; Rosanna Coppo
Journal:  Semin Immunopathol       Date:  2021-10-12       Impact factor: 9.623

Review 9.  Understanding Fc Receptor Involvement in Inflammatory Diseases: From Mechanisms to New Therapeutic Tools.

Authors:  Sanae Ben Mkaddem; Marc Benhamou; Renato C Monteiro
Journal:  Front Immunol       Date:  2019-04-12       Impact factor: 7.561

Review 10.  IgA and the intestinal microbiota: the importance of being specific.

Authors:  Oliver Pabst; Emma Slack
Journal:  Mucosal Immunol       Date:  2019-11-18       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.